Cornea Research Foundation of America, Indianapolis, Indiana; Price Vision Group, Indianapolis, Indiana, USA.
Ophthalmology. 2011 Nov;118(11):2155-60. doi: 10.1016/j.ophtha.2011.04.032. Epub 2011 Sep 9.
To evaluate graft survival, risk factors for failure, complications, and visual rehabilitation in patients who underwent Descemet's stripping endothelial keratoplasty (DSEK) under a failed penetrating keratoplasty (PK).
Retrospective interventional case series.
Sixty eyes (60 patients) treated at Price Vision Group, Indianapolis, Indiana.
Graft diameters ranged from 8 to 9 mm and were ∼1 mm larger than the previous PK. The Descemet's membrane was not stripped in the majority (54, 84%). The graft was inserted using forceps or a Busin funnel glide (Moria, Anthony, France). The probability of graft survival was calculated by Kaplan-Meier survival analysis.
Graft survival, best-corrected visual acuity (BCVA), and complications.
The mean recipient age was 68 years (range, 17-95 years). Forty eyes had 1 previous failed PK, 14 eyes had 2 previous failed PKs, and 6 eyes had 3 previous failed PKs. Thirty-one eyes (52%) had preexisting glaucoma, and 16 eyes (27%) had prior glaucoma surgery (trabeculectomy in 4, shunt procedure in 12). Fifty-five grafts were performed for visual rehabilitation, and 5 grafts were performed for pain relief. Median follow-up was 2.3 years (range, 2 months to 6 years). Median preoperative BCVA was 1.23 logarithm of the minimum angle of resolution (logMAR) (range, 0.2-3, Snellen 20/340), and median postoperative visual improvement was 0.6 logMAR (6 lines), range -0.3 to +2.7. Four eyes had graft detachment (6.6%), 7 eyes (10.5%) had endothelial rejection, and 10 eyes (16.6%) had graft failure (primary failure in 2, secondary failure in 8). The overall secondary graft survival rates were 98%, 90%, 81%, and 74% at 1, 2, 3, and 4 years, respectively. Prior glaucoma shunt was the principal risk factor for graft failure. The graft survival rates were 100%, 96%, 96%, and 96% in eyes without a prior shunt versus 93%, 74%, 44%, and 22% with a prior shunt at 1, 2, 3, and 4 years, respectively (P=0.0005; relative risk = 20). Peripheral anterior synechiae (P=0.14), neovascularization (P=0.88), endothelial rejection (P=0.59), and number of prior PKs (P=0.13) were not independent risk factors for graft failure.
Endothelial keratoplasty under a previous failed PK is a useful alternative to a repeat standard PK, particularly in eyes with an acceptable topography and refractive outcome before failure.
FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.
评估穿透性角膜移植术(PK)失败后行撕囊的内皮角膜移植术(DSEK)的移植物存活率、失败的风险因素、并发症和视力康复情况。
回顾性干预性病例系列研究。
印第安纳州印第安纳波利斯市 Price Vision Group 治疗的 60 只眼(60 例)。
移植物直径为 8 至 9 毫米,比之前的 PK 大约 1 毫米。大多数(54 例,84%)未撕除内皮层。使用镊子或 Busin 漏斗滑行器(Moria,Anthony,France)插入移植物。通过 Kaplan-Meier 生存分析计算移植物存活率。
移植物存活率、最佳矫正视力(BCVA)和并发症。
平均受者年龄为 68 岁(范围,17-95 岁)。40 只眼有 1 次先前的失败 PK,14 只眼有 2 次先前的失败 PK,6 只眼有 3 次先前的失败 PK。31 只眼(52%)有预先存在的青光眼,16 只眼(27%)有先前的青光眼手术史(4 例小梁切除术,12 例分流术)。55 只移植物用于视力康复,5 只移植物用于缓解疼痛。中位随访时间为 2.3 年(范围,2 个月至 6 年)。术前平均 BCVA 为 1.23 对数最小角分辨率(logMAR)(范围,0.2-3,Snellen 20/340),术后平均视力改善为 0.6 logMAR(6 行),范围为-0.3 至+2.7。4 只眼(6.6%)发生移植物脱离,7 只眼(10.5%)发生内皮排斥,10 只眼(16.6%)发生移植物失败(原发失败 2 只,继发失败 8 只)。整体继发性移植物存活率分别为 1 年时 98%、90%、81%和 74%,2 年时为 98%、90%、81%和 74%,3 年时为 98%、90%、81%和 74%,4 年时为 98%、90%、81%和 74%。先前有青光眼分流术是移植物失败的主要危险因素。无先前分流术的眼移植物存活率分别为 100%、96%、96%和 96%,而有先前分流术的眼分别为 93%、74%、44%和 22%,差异具有统计学意义(P=0.0005;相对风险=20)。周边前粘连(P=0.14)、新生血管形成(P=0.88)、内皮排斥(P=0.59)和先前 PK 次数(P=0.13)不是移植物失败的独立危险因素。
在先前失败的 PK 下行内皮角膜移植术是重复标准 PK 的有效替代方法,特别是在失败前具有可接受的眼压和屈光结果的眼中。
参考文献后可能会发现专有或商业披露。